The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,375.00
Bid: 11,200.00
Ask: 11,550.00
Change: -100.00 (-0.88%)
Spread: 350.00 (3.125%)
Open: 11,275.00
High: 11,200.00
Low: 11,200.00
Prev. Close: 11,300.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Interim Results

20 Jul 2017 07:00

RNS Number : 5604L
Judges Scientific PLC
20 July 2017
 

Judges Scientific PLC

 

Press Release

20 July 2017

 

Judges Scientific Plc

("Judges Scientific" or "the Group")

Trading Update and Notice of Interim Results

 

The Directors of Judges Scientific, a group involved in the buy and build of scientific instrument businesses, update shareholders and the market regarding the Group's trading performance during the first half of the current financial year.

The Group's results for the six-month period to 30 June 2017 will include a full contribution from CoolLED Limited and Dia-Stron Limited, which were acquired in the first quarter of 2016, and a first time contribution from EWB Solutions Limited which was acquired in November 2016. "Organic" in this statement excludes the performance of these businesses.

Order intake

Order intake in the first quarter was very strong, reversing the trend seen since 2014. This was followed by a good second quarter. Consequently, for the first half as a whole, the Group experienced 28.1% Organic growth in order intake from the same period last year. The Organic order book finished the first half at 16.5 weeks of sales against 11.2 weeks at 30 June 2016 and 14.9 weeks at the beginning of the period. Most Group businesses participated in this progress, including the two companies that had underperformed in 2016 due to low demand. The recent acquisitions also enjoyed satisfactory demand and booked orders in line with their annual budgets. As at 30 June 2017, the Group's total order book, which includes recently acquired companies, stood at 15.4 weeks.

First Half Performance

The healthy order book available at the end of 2016 and the continuing strength in order inflow since then, have enabled virtually all Organic businesses to increase their sales revenue in the first half compared to the same period in 2016. As a consequence, the Group experienced double digit percentage Organic sales growth on a like for like basis from the prior year. The production issues affecting one of the companies in our vacuum segment have necessitated an extensive change in its management team early this year; the company managed to deliver marginal sales growth in the first half but much remains to be done.

The Board expects the interim results to show solid progress in revenues, EBIT and earnings per share.

Full Year Outlook

The sustained strength in order intake in the last twelve months and the continued weakness of Sterling provide the Board with confidence that the Group can deliver a full year performance in line with market expectations. The recently announced acquisition of Oxford Cryosystems reinforces that confidence and reaffirms the strategic role of acquisitions in the Group's pursuit of shareholder value.

Notice of Results

The Company expects to announce its interim results for the six months to 30 June 2017 on 20 September 2017.

 

- Ends -

 

For further information please contact:

 

Judges Scientific

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

 

Media enquiries:

Abchurch (Financial Public Relations)

Julian Bosdet

Dylan Mark

Alejandra Campuzano

Tel: +44 (0) 20 7398 7714

www.abchurch-group.com

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.  The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies have been awarded five Queen's Awards for innovation and export. 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFRDFIALID
Date   Source Headline
2nd Nov 20157:00 amRNSTotal Voting Rights
21st Oct 201512:00 pmRNSNew option schemes, Director/PDMR Shareholding
16th Oct 20153:24 pmRNSDirector/PDMR Shareholding
8th Oct 20155:08 pmRNSDirector/PDMR Shareholding
7th Oct 20152:10 pmRNSDirector/PDMR Shareholding
1st Oct 20157:00 amRNSTotal Voting Rights
28th Sep 20156:00 pmRNSDirector/PDMR Shareholding
25th Sep 20157:00 amRNSHalf Yearly Report
14th Sep 20155:29 pmRNSDirector/PDMR Shareholding
1st Sep 20157:03 amRNSTotal Voting Rights
7th Aug 20157:00 amRNSDirector/PDMR Shareholding
24th Jul 20155:21 pmRNSDirector/PDMR Shareholding and Notice of Results
23rd Jul 20157:00 amRNSTrading Statement
8th Jul 20155:24 pmRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSTotal Voting Rights
8th Jun 20153:00 pmRNSDirector/PDMR Shareholding
1st Jun 20157:00 amRNSTotal Voting Rights
27th May 20152:18 pmRNSResult of AGM
22nd May 20157:00 amRNSPAYMENT OF DEFERRED CONSIDERATION
13th May 20152:17 pmRNSBlocklisting Application
6th May 20153:35 pmRNSDirector/PDMR Shareholding
29th Apr 201510:40 amRNSExercise of Options
21st Apr 201511:15 amRNSExercise of Options
16th Apr 20151:46 pmRNSIssue of Equity
9th Apr 20154:22 pmRNSDirector/PDMR Shareholding
8th Apr 20155:02 pmRNSDirector/PDMR Shareholding
31st Mar 20155:49 pmRNSDirector/PDMR Shareholding
31st Mar 20157:00 amRNSDirector/PDMR Shareholding
27th Mar 20157:00 amRNSFinal Results
11th Mar 20157:00 amRNSDirector/PDMR Shareholding
9th Mar 201512:10 pmRNSNotice of Results
3rd Mar 20157:00 amRNSAppointment of Director and Board transition
10th Feb 20154:26 pmRNSExercise of Options
9th Feb 20155:06 pmRNSDirector/PDMR Shareholding
4th Feb 20155:56 pmRNSHolding(s) in Company
4th Feb 201511:26 amRNSHolding(s) in Company
23rd Jan 201511:45 amRNSDirector/PDMR Shareholding and Exercise of Options
22nd Jan 20154:26 pmRNSDirector/PDMR Shareholding
22nd Jan 20157:00 amRNSAcquisition
20th Jan 20157:00 amRNSTrading Statement
7th Jan 201511:29 amRNSDirector/PDMR Shareholding
23rd Dec 20142:10 pmRNSNew Term Loan and Acquisition Facility
11th Nov 20143:31 pmRNSDirector/PDMR Shareholding
16th Oct 20149:42 amRNSReplacement: Director/PDMR Shareholding
8th Oct 20142:31 pmRNSDirector/PDMR Shareholding
2nd Oct 20141:53 pmRNSIssue of Equity
29th Sep 20142:49 pmRNSHolding(s) in Company
24th Sep 20147:00 amRNSHalf Yearly Report
16th Sep 20147:00 amRNSNotice of Results
10th Sep 20147:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.